{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T10:56:13Z","timestamp":1700650573424},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/2162-3619-1-39","type":"journal-article","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T17:14:36Z","timestamp":1355159676000},"source":"Crossref","is-referenced-by-count":7,"title":["French \u201creal life\u201d experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia"],"prefix":"10.1186","volume":"1","author":[{"given":"Pascale","family":"Trioche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Nelken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Pellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Rohrlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Sirvent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Boutard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Margueritte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Pautard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Ducassou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Plantaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristell","family":"Desseaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Baruchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,10]]},"reference":[{"key":"45_CR1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1365-2141.2005.05773.x","volume":"131","author":"PS Gaynon","year":"2005","unstructured":"Gaynon PS: Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol 2005, 131: 579\u2013587. 10.1111\/j.1365-2141.2005.05773.x","journal-title":"Br J Haematol"},{"key":"45_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui CH, Evans WE: Treatment of acute lymphoblastic leukemia. N Engl J Med 2006, 354: 166\u2013178. 10.1056\/NEJMra052603","journal-title":"N Engl J Med"},{"key":"45_CR3","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1200\/JCO.2008.16.1414","volume":"26","author":"EA Raetz","year":"2008","unstructured":"Raetz EA, Borowitz MJ, Devidas M, Linda SB, Hunger SP, Winick NJ, Camitta BM, Gaynon PS, Carroll WL: Reinduction platform for children with first marrow relapse of acute lymphoblastic leukemia: a children\u2019s oncology group study. J Clin Oncol 2008, 26: 3971\u20133978. 10.1200\/JCO.2008.16.1414","journal-title":"J Clin Oncol"},{"key":"45_CR4","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.1200\/JCO.2007.10.7508","volume":"36","author":"S Malempati","year":"2007","unstructured":"Malempati S, Gaynon PS, Sather H, La MK, Stork LC: Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: children\u2019s oncology group study CCG-1952. J Clin Oncol 2007, 36: 5800\u20135807.","journal-title":"J Clin Oncol"},{"key":"45_CR5","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1038\/leu.2008.251","volume":"22","author":"K Nguyen","year":"2008","unstructured":"Nguyen K, Devidas M, Cheng SC, La M, Raetz EA, Carroll WL, Winick NJ, Hunger SP, Gaynon PS, Loh ML: Factors influencing survival after relapse from acute lymphoblastic leukemia: a children\u2019s oncology group study. Leukemia 2008, 22: 2142\u20132150. 10.1038\/leu.2008.251","journal-title":"Leukemia"},{"key":"45_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1200\/JCO.2009.22.2950","volume":"28","author":"RH Ko","year":"2010","unstructured":"Ko RH, Ji L, Barnette P, Bostrom B, Hutchinson R, Raetz E, Seibel NL, Twist CJ, Eckroth E, Sposto R, Gaynon PS, Loh ML: Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia consortium study. J Clin Oncol 2010, 28: 648\u2013654. 10.1200\/JCO.2009.22.2950","journal-title":"J Clin Oncol"},{"key":"45_CR7","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1517\/14656566.6.15.2711","volume":"6","author":"JP Kline","year":"2005","unstructured":"Kline JP, Larson RA: Clofarabine in the treatment of acute myeloid leukemia and acute lymphoblastic leukemia: a review. Expert Opin Pharmacother 2005, 6: 2711\u20132718. 10.1517\/14656566.6.15.2711","journal-title":"Expert Opin Pharmacother"},{"key":"45_CR8","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nrd2055","volume":"5","author":"PL Bonate","year":"2006","unstructured":"Bonate PL, Arthaud L, Cantrell WR Jr, Stephenson K, Weitman S, Secrist JA 3rd: Discovery and development of clofarabine: a nucleoside analogue for treating cancer. Nat Rev Drug Discov 2006, 5: 855\u2013863. 10.1038\/nrd2055","journal-title":"Nat Rev Drug Discov"},{"key":"45_CR9","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1080\/10428190701545644","volume":"48","author":"HM Kantarjian","year":"2007","unstructured":"Kantarjian HM, Jeha S, Gandhi V, Wess M, Faderl S: Clofarabine: past, present, and future. Leuk Lymphoma 2007, 48: 1922\u20131930. 10.1080\/10428190701545644","journal-title":"Leuk Lymphoma"},{"key":"45_CR10","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/molecules14031183","volume":"14","author":"T Robak","year":"2009","unstructured":"Robak T, Korycka A, Lech-Maranda E, Robak P: Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases. Molecules 2009, 14: 1183\u20131226. 10.3390\/molecules14031183","journal-title":"Molecules"},{"key":"45_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1517\/13543784.2011.554822","volume":"20","author":"T Robak","year":"2011","unstructured":"Robak T: New nucleoside analogs for patients with hematological malignancies. Expert Opin Investig Drugs 2011, 20: 343\u2013359. 10.1517\/13543784.2011.554822","journal-title":"Expert Opin Investig Drugs"},{"key":"45_CR12","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1200\/JCO.2003.04.031","volume":"21","author":"HM Kantarjian","year":"2003","unstructured":"Kantarjian HM, Gandhi V, Kozuch P, Faderl S, Giles F, Cortes J, O\u2019Brien S, Ibrahim N, Khuri F, Du M, Rios MB, Jeha S, McLaughlin P, Plunkett W, Keating M: Phase 1 clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers. J Clin Oncol 2003, 21: 1167\u20131173. 10.1200\/JCO.2003.04.031","journal-title":"J Clin Oncol"},{"key":"45_CR13","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1182\/blood-2003-03-0925","volume":"102","author":"H Kantarjian","year":"2003","unstructured":"Kantarjian H, Gandhi V, Cortes J, Verstovsek S, Du M, Garcia-Manero G, Giles F, Faderl S, O\u2019Brien S, Jeha S, Davis J, Shaked Z, Craig A, Keating M, Plunkett W, Freireich EJ: Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia. Blood 2003, 102: 2379\u20132386. 10.1182\/blood-2003-03-0925","journal-title":"Blood"},{"key":"45_CR14","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1182\/blood-2003-06-2122","volume":"103","author":"S Jeha","year":"2004","unstructured":"Jeha S, Gandhi V, Chan KW, McDonald L, Ramirez I, Madden R, Rytting M, Brandt M, Keating M, Plunkett W, Kantarjian H: Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. Blood 2004, 103: 784\u2013789.","journal-title":"Blood"},{"key":"45_CR15","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1200\/JCO.2005.03.8554","volume":"24","author":"S Jeha","year":"2006","unstructured":"Jeha S, Gaynon PS, Razzouk BI, Franklin J, Kadota R, Shen V, Luchtman-Jones L, Rytting M, Bomgaars LR, Rheingold S, Ritchey K, Albano E, Arceci RJ, Goldman S, Griffin T, Altman A, Gordon B, Steinherz L, Weitman S, Steinherz P: Phase 2 study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. J Clin Oncol 2006, 24: 1917\u20131923. 10.1200\/JCO.2005.03.8554","journal-title":"J Clin Oncol"},{"key":"45_CR16","first-page":"108","volume":"2006","author":"P Kearns","year":"1859","unstructured":"Kearns P, Michel G, Nelken B, Joel S, Al-Ghazaly E, Beishuizen A, Conter V, Gadner H, Henze G, Smith H, Baruchel A, Saha V: BIOV-111 a European phase 2 trial of clofarabine (Evoltra\u00ae) in refractory and relapsed childhood acute lymphoblastic leukemia [abstract]. Blood 1859, 2006: 108.","journal-title":"Blood"},{"key":"45_CR17","first-page":"3580","volume":"7","author":"T Yamauchi","year":"2001","unstructured":"Yamauchi T, Nowak BJ, Keating MJ, Plunkett W: DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. Clin Cancer Res 2001, 7: 3580\u20133589.","journal-title":"Clin Cancer Res"},{"key":"45_CR18","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1182\/blood-2007-03-081364","volume":"110","author":"JE Karp","year":"2007","unstructured":"Karp JE, Ricklis RM, Balakrishnan K, Briel J, Greer J, Gore SD, Smith BD, McDevitt MA, Carraway H, Levis MJ, Gandhi V: A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias. Blood 2007, 110: 1762\u20131769. 10.1182\/blood-2007-03-081364","journal-title":"Blood"},{"key":"45_CR19","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1038\/leu.2009.185","volume":"23","author":"N Hijiya","year":"2009","unstructured":"Hijiya N, Gaynon P, Barry E, Silverman L, Thomson B, Chu R, Cooper T, Kadota R, Rytting M, Steinherz P, Shen V, Jeha S, Abichandani R, Carroll WL: A multi-center phase 1 study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia. Leukemia 2009, 23: 2259\u20132264. 10.1038\/leu.2009.185","journal-title":"Leukemia"},{"key":"45_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2141.2009.07882.x","volume":"147","author":"F Locatelli","year":"2009","unstructured":"Locatelli F, Testi AM, Bernardo ME, Rizzari C, Bertaina A, Merli P, Pession A, Giraldi E, Parasole R, Barberi W, Zecca M: Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory\/multiple relapsed acute lymphoblastic leukemia. Br J Haematol 2009, 147: 371\u2013378. 10.1111\/j.1365-2141.2009.07882.x","journal-title":"Br J Haematol"},{"key":"45_CR21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","volume":"21","author":"VHJ Van der Velden","year":"2007","unstructured":"Van der Velden VHJ, Cazzaniga G, Schrauder A, Hancock J, Bader P, Panzer-Grumayer ER, Flohr T, Sutton R, Cave H, Madsen HO, Cayuela JM, Trka J, Eckert C, Foroni L, Zur Stadt U, Beldjord K, Raff T, Van Der Schoot CE, Van Dongen JJM: Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia 2007, 21: 604\u2013611.","journal-title":"Leukemia"},{"key":"45_CR22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-2141.2011.08752.x","volume":"154","author":"D O\u2019Connor","year":"2011","unstructured":"O\u2019Connor D, Sibson K, Caswell M, Connor P, Cummins M, Mitchell C, Motwani J, Taj M, Vora A, Wynn R, Kearns PR: Early UK experience in the use of clofarabine in the treatment of relapsed and refractory pediatric acute lymphoblastic leukemia. Br J Haematol 2011, 154: 482\u2013485. 10.1111\/j.1365-2141.2011.08752.x","journal-title":"Br J Haematol"},{"key":"45_CR23","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1182\/blood-2011-08-374710","volume":"118","author":"N Hijiya","year":"2011","unstructured":"Hijiya N, Thomson B, Isakoff MS, Silverman LB, Steinherz PG, Borowitz MJ, Kadota R, Cooper T, Shen V, Dahl G, Thottassery JV, Jeha S, Maloney K, Paul JA, Barry E, Caroll WL, Gaynon S: Phase II trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory\/relapsed acute lymphoblastic leukemia. Blood 2011, 118: 6043\u20136049. 10.1182\/blood-2011-08-374710","journal-title":"Blood"},{"key":"45_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-2141.2011.08847.x","volume":"156","author":"H Inaba","year":"2012","unstructured":"Inaba H, Bhojwani D, Pauley JL, Pei D, Cheng C, Metzger ML, Howard SC, Rubnitz JE, Sandlund JT, Ribeiro RC, Leung W, Campana D, Pui CH, Jeha S: Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies. Br J Haematol 2012, 156: 275\u2013279. 10.1111\/j.1365-2141.2011.08847.x","journal-title":"Br J Haematol"}],"container-title":["Experimental Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2162-3619-1-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2162-3619-1-39\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2162-3619-1-39.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T11:16:58Z","timestamp":1548155818000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/2162-3619-1-39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["45"],"URL":"https:\/\/doi.org\/10.1186\/2162-3619-1-39","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"article-number":"39"}}